Report Detail
Global Recombinant Cytokines Drug Sales Market Report 2021
- RnM3818178 |
- 14 June, 2021 |
- Global |
- 140 Pages |
- QYResearch |
- Pharma & Healthcare
Cytokines are a broad and loose category of small proteins (~5–20 kDa) that are important in cell signaling. Cytokines are peptides, and cannot cross the lipid bilayer of cells to enter the cytoplasm. Cytokines have been shown to be involved in autocrine signaling, paracrine signaling and endocrine signaling as immunomodulating agents. Their definite distinction from hormones is still part of ongoing research. Cytokines include chemokines, interferons, interleukins, lymphokines, and tumour necrosis factors, but generally not hormones or growth factors (despite some overlap in the terminology). Cytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and various stromal cells; a given cytokine may be produced by more than one type of cell.
Some cytokines have been developed into protein therapeutics using recombinant DNA technology. Recombinant cytokines being used as drugs as of 2014 include:
Bone morphogenetic protein (BMP), used to treat bone-related conditions
Erythropoietin (EPO), used to treat anemia
Granulocyte colony-stimulating factor (G-CSF), used to treat neutropenia in cancer patients
Granulocyte macrophage colony-stimulating factor (GM-CSF), used to treat neutropenia and fungal infections in cancer patients
Interferon alfa, used to treat hepatitis C and multiple sclerosis
Interferon beta, used to treat multiple sclerosis
Interleukin 2 (IL-2), used to treat cancer.
Interleukin 11 (IL-11), used to treat thrombocytopenia in cancer patients.
Interferon gamma is used to treat chronic granulomatous disease and osteopetrosis
Market Analysis and Insights: Global Recombinant Cytokines Drug Market
The global Recombinant Cytokines Drug market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Recombinant Cytokines Drug Scope and Market Size
The global Recombinant Cytokines Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Cytokines Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Interferon
Recombinant Human Granulocyte Colony-Stimulating
Erythropoietin (EPO)
Recombinant Human Thrombopoietin
Others
Segment by Application
Hepatitis B
Hepatitis C
Multiple Sclerosis
Tumor Therapy
Wound Healing
Others
The Recombinant Cytokines Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Cytokines Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Merck
Bayer
Biogen Idec
Gensci
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Abcam plc
R&D Systems
Thermo Fisher Scientific
BioLegend
Invitrogen
OriGene
Biorbyt
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
1 Recombinant Cytokines Drug Market Overview
- 1.1 Recombinant Cytokines Drug Product Scope
- 1.2 Recombinant Cytokines Drug Segment by Type
- 1.2.1 Global Recombinant Cytokines Drug Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Interferon
- 1.2.3 Recombinant Human Granulocyte Colony-Stimulating
- 1.2.4 Erythropoietin (EPO)
- 1.2.5 Recombinant Human Thrombopoietin
- 1.2.6 Others
- 1.3 Recombinant Cytokines Drug Segment by Application
- 1.3.1 Global Recombinant Cytokines Drug Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Hepatitis B
- 1.3.3 Hepatitis C
- 1.3.4 Multiple Sclerosis
- 1.3.5 Tumor Therapy
- 1.3.6 Wound Healing
- 1.3.7 Others
- 1.4 Recombinant Cytokines Drug Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Recombinant Cytokines Drug Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Recombinant Cytokines Drug Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Recombinant Cytokines Drug Price Trends (2016-2027)
2 Recombinant Cytokines Drug Estimates and Forecasts by Region
- 2.1 Global Recombinant Cytokines Drug Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Recombinant Cytokines Drug Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Recombinant Cytokines Drug Sales Market Share by Region (2016-2021)
- 2.2.2 Global Recombinant Cytokines Drug Revenue Market Share by Region (2016-2021)
- 2.3 Global Recombinant Cytokines Drug Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Recombinant Cytokines Drug Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Recombinant Cytokines Drug Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Recombinant Cytokines Drug Estimates and Projections (2016-2027)
- 2.4.2 Europe Recombinant Cytokines Drug Estimates and Projections (2016-2027)
- 2.4.3 China Recombinant Cytokines Drug Estimates and Projections (2016-2027)
- 2.4.4 Japan Recombinant Cytokines Drug Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Recombinant Cytokines Drug Estimates and Projections (2016-2027)
- 2.4.6 India Recombinant Cytokines Drug Estimates and Projections (2016-2027)
3 Global Recombinant Cytokines Drug Competition Landscape by Players
- 3.1 Global Top Recombinant Cytokines Drug Players by Sales (2016-2021)
- 3.2 Global Top Recombinant Cytokines Drug Players by Revenue (2016-2021)
- 3.3 Global Recombinant Cytokines Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Cytokines Drug as of 2020)
- 3.4 Global Recombinant Cytokines Drug Average Price by Company (2016-2021)
- 3.5 Manufacturers Recombinant Cytokines Drug Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Cytokines Drug Market Size by Type
- 4.1 Global Recombinant Cytokines Drug Historic Market Review by Type (2016-2021)
- 4.1.1 Global Recombinant Cytokines Drug Sales Market Share by Type (2016-2021)
- 4.1.2 Global Recombinant Cytokines Drug Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Recombinant Cytokines Drug Price by Type (2016-2021)
- 4.2 Global Recombinant Cytokines Drug Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Recombinant Cytokines Drug Sales Forecast by Type (2022-2027)
- 4.2.2 Global Recombinant Cytokines Drug Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Recombinant Cytokines Drug Price Forecast by Type (2022-2027)
5 Global Recombinant Cytokines Drug Market Size by Application
- 5.1 Global Recombinant Cytokines Drug Historic Market Review by Application (2016-2021)
- 5.1.1 Global Recombinant Cytokines Drug Sales Market Share by Application (2016-2021)
- 5.1.2 Global Recombinant Cytokines Drug Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Recombinant Cytokines Drug Price by Application (2016-2021)
- 5.2 Global Recombinant Cytokines Drug Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Recombinant Cytokines Drug Sales Forecast by Application (2022-2027)
- 5.2.2 Global Recombinant Cytokines Drug Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Recombinant Cytokines Drug Price Forecast by Application (2022-2027)
6 North America Recombinant Cytokines Drug Market Facts & Figures
- 6.1 North America Recombinant Cytokines Drug Sales by Company
- 6.1.1 North America Recombinant Cytokines Drug Sales by Company (2016-2021)
- 6.1.2 North America Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 6.2 North America Recombinant Cytokines Drug Sales Breakdown by Type
- 6.2.1 North America Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 6.3 North America Recombinant Cytokines Drug Sales Breakdown by Application
- 6.3.1 North America Recombinant Cytokines Drug Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Recombinant Cytokines Drug Sales Breakdown by Application (2022-2027)
7 Europe Recombinant Cytokines Drug Market Facts & Figures
- 7.1 Europe Recombinant Cytokines Drug Sales by Company
- 7.1.1 Europe Recombinant Cytokines Drug Sales by Company (2016-2021)
- 7.1.2 Europe Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 7.2 Europe Recombinant Cytokines Drug Sales Breakdown by Type
- 7.2.1 Europe Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 7.3 Europe Recombinant Cytokines Drug Sales Breakdown by Application
- 7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)
8 China Recombinant Cytokines Drug Market Facts & Figures
- 8.1 China Recombinant Cytokines Drug Sales by Company
- 8.1.1 China Recombinant Cytokines Drug Sales by Company (2016-2021)
- 8.1.2 China Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 8.2 China Recombinant Cytokines Drug Sales Breakdown by Type
- 8.2.1 China Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 8.2.2 China Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 8.3 China Recombinant Cytokines Drug Sales Breakdown by Application
- 8.3.1 China 311 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Recombinant Cytokines Drug Market Facts & Figures
- 9.1 Japan Recombinant Cytokines Drug Sales by Company
- 9.1.1 Japan Recombinant Cytokines Drug Sales by Company (2016-2021)
- 9.1.2 Japan Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 9.2 Japan Recombinant Cytokines Drug Sales Breakdown by Type
- 9.2.1 Japan Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 9.3 Japan Recombinant Cytokines Drug Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Recombinant Cytokines Drug Market Facts & Figures
- 10.1 Southeast Asia Recombinant Cytokines Drug Sales by Company
- 10.1.1 Southeast Asia Recombinant Cytokines Drug Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 10.2 Southeast Asia Recombinant Cytokines Drug Sales Breakdown by Type
- 10.2.1 Southeast Asia Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Recombinant Cytokines Drug Sales Breakdown by Application
- 10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)
11 India Recombinant Cytokines Drug Market Facts & Figures
- 11.1 India Recombinant Cytokines Drug Sales by Company
- 11.1.1 India Recombinant Cytokines Drug Sales by Company (2016-2021)
- 11.1.2 India Recombinant Cytokines Drug Revenue by Company (2016-2021)
- 11.2 India Recombinant Cytokines Drug Sales Breakdown by Type
- 11.2.1 India Recombinant Cytokines Drug Sales Breakdown by Type (2016-2021)
- 11.2.2 India Recombinant Cytokines Drug Sales Breakdown by Type (2022-2027)
- 11.3 India Recombinant Cytokines Drug Sales Breakdown by Application
- 11.3.1 India Recombinant Cytokines Drug Sales Breakdown by Application (2016-2021)
- 11.3.2 India Recombinant Cytokines Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Recombinant Cytokines Drug Business
- 12.1 Roche
- 12.1.1 Roche Corporation Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Roche Recombinant Cytokines Drug Products Offered
- 12.1.5 Roche Recent Development
- 12.2 Merck
- 12.2.1 Merck Corporation Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Merck Recombinant Cytokines Drug Products Offered
- 12.2.5 Merck Recent Development
- 12.3 Bayer
- 12.3.1 Bayer Corporation Information
- 12.3.2 Bayer Business Overview
- 12.3.3 Bayer Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Bayer Recombinant Cytokines Drug Products Offered
- 12.3.5 Bayer Recent Development
- 12.4 Biogen Idec
- 12.4.1 Biogen Idec Corporation Information
- 12.4.2 Biogen Idec Business Overview
- 12.4.3 Biogen Idec Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Biogen Idec Recombinant Cytokines Drug Products Offered
- 12.4.5 Biogen Idec Recent Development
- 12.5 Gensci
- 12.5.1 Gensci Corporation Information
- 12.5.2 Gensci Business Overview
- 12.5.3 Gensci Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Gensci Recombinant Cytokines Drug Products Offered
- 12.5.5 Gensci Recent Development
- 12.6 Huaxin
- 12.6.1 Huaxin Corporation Information
- 12.6.2 Huaxin Business Overview
- 12.6.3 Huaxin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Huaxin Recombinant Cytokines Drug Products Offered
- 12.6.5 Huaxin Recent Development
- 12.7 Triprime
- 12.7.1 Triprime Corporation Information
- 12.7.2 Triprime Business Overview
- 12.7.3 Triprime Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Triprime Recombinant Cytokines Drug Products Offered
- 12.7.5 Triprime Recent Development
- 12.8 Sinovac
- 12.8.1 Sinovac Corporation Information
- 12.8.2 Sinovac Business Overview
- 12.8.3 Sinovac Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Sinovac Recombinant Cytokines Drug Products Offered
- 12.8.5 Sinovac Recent Development
- 12.9 Zhaoke
- 12.9.1 Zhaoke Corporation Information
- 12.9.2 Zhaoke Business Overview
- 12.9.3 Zhaoke Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Zhaoke Recombinant Cytokines Drug Products Offered
- 12.9.5 Zhaoke Recent Development
- 12.10 Kawin
- 12.10.1 Kawin Corporation Information
- 12.10.2 Kawin Business Overview
- 12.10.3 Kawin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Kawin Recombinant Cytokines Drug Products Offered
- 12.10.5 Kawin Recent Development
- 12.11 Abcam plc
- 12.11.1 Abcam plc Corporation Information
- 12.11.2 Abcam plc Business Overview
- 12.11.3 Abcam plc Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Abcam plc Recombinant Cytokines Drug Products Offered
- 12.11.5 Abcam plc Recent Development
- 12.12 R&D Systems
- 12.12.1 R&D Systems Corporation Information
- 12.12.2 R&D Systems Business Overview
- 12.12.3 R&D Systems Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 R&D Systems Recombinant Cytokines Drug Products Offered
- 12.12.5 R&D Systems Recent Development
- 12.13 Thermo Fisher Scientific
- 12.13.1 Thermo Fisher Scientific Corporation Information
- 12.13.2 Thermo Fisher Scientific Business Overview
- 12.13.3 Thermo Fisher Scientific Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 Thermo Fisher Scientific Recombinant Cytokines Drug Products Offered
- 12.13.5 Thermo Fisher Scientific Recent Development
- 12.14 BioLegend
- 12.14.1 BioLegend Corporation Information
- 12.14.2 BioLegend Business Overview
- 12.14.3 BioLegend Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 BioLegend Recombinant Cytokines Drug Products Offered
- 12.14.5 BioLegend Recent Development
- 12.15 Invitrogen
- 12.15.1 Invitrogen Corporation Information
- 12.15.2 Invitrogen Business Overview
- 12.15.3 Invitrogen Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Invitrogen Recombinant Cytokines Drug Products Offered
- 12.15.5 Invitrogen Recent Development
- 12.16 OriGene
- 12.16.1 OriGene Corporation Information
- 12.16.2 OriGene Business Overview
- 12.16.3 OriGene Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 OriGene Recombinant Cytokines Drug Products Offered
- 12.16.5 OriGene Recent Development
- 12.17 Biorbyt
- 12.17.1 Biorbyt Corporation Information
- 12.17.2 Biorbyt Business Overview
- 12.17.3 Biorbyt Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 Biorbyt Recombinant Cytokines Drug Products Offered
- 12.17.5 Biorbyt Recent Development
- 12.18 Qilu Pharmaceutical
- 12.18.1 Qilu Pharmaceutical Corporation Information
- 12.18.2 Qilu Pharmaceutical Business Overview
- 12.18.3 Qilu Pharmaceutical Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.18.4 Qilu Pharmaceutical Recombinant Cytokines Drug Products Offered
- 12.18.5 Qilu Pharmaceutical Recent Development
- 12.19 Shijiazhuang Pharmaceutical
- 12.19.1 Shijiazhuang Pharmaceutical Corporation Information
- 12.19.2 Shijiazhuang Pharmaceutical Business Overview
- 12.19.3 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.19.4 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Products Offered
- 12.19.5 Shijiazhuang Pharmaceutical Recent Development
- 12.20 Amgen
- 12.20.1 Amgen Corporation Information
- 12.20.2 Amgen Business Overview
- 12.20.3 Amgen Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.20.4 Amgen Recombinant Cytokines Drug Products Offered
- 12.20.5 Amgen Recent Development
- 12.21 Johnson & Johnson
- 12.21.1 Johnson & Johnson Corporation Information
- 12.21.2 Johnson & Johnson Business Overview
- 12.21.3 Johnson & Johnson Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.21.4 Johnson & Johnson Recombinant Cytokines Drug Products Offered
- 12.21.5 Johnson & Johnson Recent Development
- 12.22 Kyowa Hakko Kirin
- 12.22.1 Kyowa Hakko Kirin Corporation Information
- 12.22.2 Kyowa Hakko Kirin Business Overview
- 12.22.3 Kyowa Hakko Kirin Recombinant Cytokines Drug Sales, Revenue and Gross Margin (2016-2021)
- 12.22.4 Kyowa Hakko Kirin Recombinant Cytokines Drug Products Offered
- 12.22.5 Kyowa Hakko Kirin Recent Development
13 Recombinant Cytokines Drug Manufacturing Cost Analysis
- 13.1 Recombinant Cytokines Drug Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Recombinant Cytokines Drug
- 13.4 Recombinant Cytokines Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Recombinant Cytokines Drug Distributors List
- 14.3 Recombinant Cytokines Drug Customers
15 Market Dynamics
- 15.1 Recombinant Cytokines Drug Market Trends
- 15.2 Recombinant Cytokines Drug Drivers
- 15.3 Recombinant Cytokines Drug Market Challenges
- 15.4 Recombinant Cytokines Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Recombinant Cytokines Drug. Industry analysis & Market Report on Recombinant Cytokines Drug is a syndicated market report, published as Global Recombinant Cytokines Drug Sales Market Report 2021. It is complete Research Study and Industry Analysis of Recombinant Cytokines Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
